Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Boldo for Overactive Bladder
NCT06162065Phase 1Unknown
- Sponsor
- Universidad de Valparaíso
- Start
- Nov 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Universidad de Valparaíso. Primary endpoints: Urinary symptoms at 1 month, Bladder Control Self-Assessment Questionnaire at 1 month and 1 more. Status: unknown.
Beyond the preview
Go deeper on NCT06162065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06162065.